Family Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,290
Closed -$557K 75
2017
Q2
$557K Sell
2,290
-11,433
-83% -$2.69M 0.38% 34
2017
Q1
$3.28M Sell
13,723
-1,958
-12% -$456K 2.26% 21
2016
Q4
$3.29M Sell
15,681
-1,380
-8% -$286K 2.25% 20
2016
Q3
$3.93M Sell
17,061
-10
-0.1% -$2.44K 2.22% 21
2016
Q2
$3.94M Buy
17,071
+5,404
+46% +$1.25M 2.23% 19
2016
Q1
$3.13M Buy
11,667
+1,596
+16% +$457K 2.03% 19
2015
Q4
$3.15M Buy
10,071
+1,670
+20% +$497K 1.63% 21
2015
Q3
$2.28M Buy
8,401
+3,860
+85% +$1.19M 1.01% 36
2015
Q2
$1.38M Buy
+4,541
New +$1.35M 0.57% 52

Other funds holding AGN

Family Management's AGN Position: Q3 2017 in Review

Family Management sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 2,290 shares — an estimated $557K sold.

Family Management first reported a position in AGN in Q2 2015 and held it in 9 quarters. The position peaked at $3.94M in Q2 2016. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Family Management reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Family Management sold 2,290 Allergan plc shares in Q3 2017, an estimated $557K.
  • Family Management first reported a position in Allergan plc in Q2 2015 and held it in 9 quarters.
  • Family Management's Allergan plc position peaked at $3.94M in Q2 2016.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Family Management's 13F filing for Q3 2017, filed 13 Nov 2017.